Publications by authors named "Aviral Singh"

Claim this Profile
T
The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy.
Aviral Singh, Sebastian Sanduleanu, Harshad R Kulkarni, Thomas Langbein, Philippe Lambin

Front Endocrinol (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Functional neuroendocrine tumors.
Bojana Popovic, Francesca Spada, Aviral Singh, Karin Zibar Tomsic

Front Endocrinol (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DuReS: An R Package for Denoising Experimental Tandem Mass Spectra and Metabolite Annotation.
Shayantan Banerjee, Prajval Nakrani, Aviral Singh, Pramod P Wangikar

Anal Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MythicVision: a deep learning powered mobile application for understanding Indian mythological deities using weight centric decision approach.
Tauseef Khan, Aditya Nitin Patil, Aviral Singh, Gitesh Prashant Bhavsar, Kanakagiri Sujay Ashrith

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Mike M Sathekge, Ismaheel O Lawal, Chandrasekhar Bal, Frank Bruchertseifer, Sajana Ballal, Aviral Singh

Lancet Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using Lu-FAP-2286: First-in-Humans Results.
Richard P Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C Robiller

J Nucl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Humans Application of Tb: A Feasibility Study Using Tb-DOTATOC.
Richard P Baum, Aviral Singh, Harshad R Kulkarni, Peter Bernhardt, Tobias Rydén

J Nucl Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Outcome and Safety of Re-challenge Lutetium-177 PSMA (Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer-a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report.
Masha Maharaj, Lucille Heslop, Trisha Govender, Nisaar Korowlay, Aviral Singh

Nucl Med Mol Imaging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy.
Jingjing Zhang, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R Kulkarni

J Nucl Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
Lisa Bodei, Mark S Kidd, Aviral Singh, Wouter A van der Zwan, Stefano Severi

Eur J Nucl Med Mol Imaging· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-Year Survival of a Patient With Lymph Node, Pulmonary, Bone, Cardiac and Intraspinal Metastases of a Rectal Neuroendocrine Neoplasm Treated With Peptide Receptor Radionuclide Therapy-The Value of Salvage Peptide Receptor Radionuclide Therapy.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Richard P Baum

Clin Nucl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Intra-arterial Peptide Receptor Radionuclide Therapy of DOTATOC-Negative High-Grade Liver Metastases of a Pancreatic Neuroendocrine Neoplasm Using 177Lu-DOTA-LM3: A Somatostatin Receptor Antagonist.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Richard P Baum

Clin Nucl Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Regression of Lung Metastases in a Patient With Metastatic Castration-Resistant Prostate Cancer Using 177Lu-PSMA Radioligand Therapy.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Richard P Baum

Clin Nucl Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Nasopharyngeal Carcinoma Treated With Intraarterial Combined With Intravenous Peptide Receptor Radionuclide Therapy.
Wenjia Zhu, Jingjing Zhang, Aviral Singh, Harshad R Kulkarni, Richard P Baum

Clin Nucl Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Christiane Schuchardt, Karin Niepsch

J Nucl Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients.
Else A Aalbersberg, Daphne M V Huizing, Iris Walraven, Berlinda J de Wit-van der Veen, Harshad R Kulkarni, Aviral Singh

J Nucl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Bench to Bedside-The Bad Berka Experience With First-in-Human Studies.
Jingjing Zhang, Aviral Singh, Harshad R Kulkarni, Christiane Schuchardt, Dirk Müller

Semin Nucl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy.
Thomas W Barber, Aviral Singh, Harshad R Kulkarni, Karin Niepsch, Baki Billah

J Nucl Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical investigations and first-in-human application of Tb-PSMA-617 for PET/CT imaging of prostate cancer.
Cristina Müller, Aviral Singh, Christoph A Umbricht, Harshad R Kulkarni, Karl Johnston

EJNMMI Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen Accumulation in Lower Extremity Lymphedema.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Richard P Baum

Clin Nucl Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Karin Niepsch, Dirk Müller

J Nucl Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Response (Partial Remission) 3 Years After Peptide Receptor Radionuclide Therapy in a Patient Participating in the NETTER-1 Trial.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Richard P Baum

Clin Nucl Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer.
Finn Edler von Eyben, Aviral Singh, Jingjing Zhang, Karin Nipsch, Danielle Meyrick

Oncotarget· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and Delivery After PRRT Without Sequelae.
Jingjing Zhang, Harshad R Kulkarni, Coline Lehmann, Aviral Singh, Richard P Baum

Clin Nucl Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine Neoplasm.
Jingjing Zhang, Harshad R Kulkarni, Aviral Singh, Richard P Baum

Clin Nucl Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis